RightFit
Not yet recruitingNot applicable

Understanding the Role of MyCareGorithm as a Visual Digital Platforms in Cancer Treatment Education and Patient Comprehension of Oncology Treatment Plans

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years to 100 Years
Sex
All sexes
Healthy volunteers
Accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Procedures mentioned: Questionnaires

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "Specifically, the study seeks to answer the scientific question: • Do at least 75% of newly diagnosed head and neck and prostate cancer patients report being "satisfied" (≥4 positive responses on a 6-item survey) after use of the digital communication tool, and is this proportion significantly greater than 50%?"
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests whether MyCareGorithm, a digital communication tool, helps patients and caregivers understand cancer and the treatment plan after their first visit with a doctor or nurse practitioner. It focuses on head and neck cancer, though the eligibility rules also mention prostate cancer. Patients, caregivers, and providers may take part.

The purpose of this research study is to learn if a digital communication tool can improve how well patients with head and neck cancer and their caregivers understand the disease and treatment plan after their first consultation visit with the doctor/nurse practitioner.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Patients: Must be 18 to 100 years old.
  • Patients: Must have head and neck cancer of any type.
  • Patients: Must receive treatment at MDACC. This rule lists both head and neck cancer and prostate cancer.
  • Patients and caregivers: Must speak and understand English.
  • Caregivers: Must be at least 18 and care for a patient who meets the study rules.
  • Providers: Must be doctors or nurse practitioners who treat cancer with radiation and take part in first visits for patients with head and neck cancer and prostate cancer.
  • Providers: Must complete a survey after the visit.

Who can't join

  • Patients: Cannot join without a diagnosis of head and neck cancer or prostate cancer.
  • Patients and caregivers: Cannot join if they do not speak English, because the tool is not translated.
  • Caregivers: Cannot join if they do not care for an eligible patient.
  • Providers: Cannot join if they do not practice cancer care using radiation and are not part of the first visit.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: Patients * Adults aged 18 to 100 years. * Diagnosed with head and neck cancer (all histologies included). * Receiving treatment for head and neck and prostate cancer at MDACC * Able to speak and understand English Caregivers * Adults (≥18 years old). * Identified as a caregiver to a patient who meets the above patient inclusion criteria. * Able to speak and understand English. Providers * Doctors or nurse practitioners practicing in the field of radiation oncology and actively participating in initial consultations for patients with head and neck cancer and prostate cancer. * Must complete the provider survey after the consultation. Exclusion Criteria: Patients * Individuals without a diagnosis of head and neck cancer or prostate cancer. * Patients who do not speak English (since the digital tool is not translated). Caregivers * Adults who are not caregivers of the eligible patient * Caregivers who do not speak English (tool not translated). Providers * Doctors or nurse practitioners not practicing in the field of radiation oncology and not part of the initial consultation process.

Study sites (1)

TX